Lumbar Transforaminal Anterior Epidural Steroid Injections in Discogenic Low Back Pain

Sponsor
Marmara University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04930211
Collaborator
(none)
40
1
2
24
1.7

Study Details

Study Description

Brief Summary

Modic changes have been associated with low back pain in many clinical studies and are often considered a part of the disc degeneration process. Modic type 1 change is considered an inflammatory process. The aim of this study is to determine the effectiveness of lumbar transforaminal epidural steroid injections in Modic type-1 changes.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

Modic changes have been associated with low back pain in many clinical studies and are often considered a part of the disc degeneration process. However, in degenerative disc disease, whether the pain could be attributed to Modic changes or not is still a matter of debate.

There are different options in the treatment of low back pain due to degenerative disc disease (DDD) and Modic changes. Conservative treatments and surgical approaches are some of them. Other interventional procedures include intradiscal and epidural steroid injections which have relatively less risk of complications than surgery.

The only study in the literature investigating the effectiveness of epidural steroid injections in patients with low back pain associated with modic changes belongs to Butterman et al. They reported that patients with Modic changes (type 1) responded better to epidural steroid injections than those without endplate irregularities. However, they did not report the details of the procedure, such as the steroid and local anesthetic they used, the amount of them and the level of the procedure. Moreover, they used different approaches including interlaminar and transforaminal, which may be misleading while interpreting the results.

Based on these results, the aim of this study is to determine the effectiveness of lumbar transforaminal epidural steroid injections in Modic type-1 changes.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effectiveness of Lumbar Transforaminal Anterior Epidural Steroid Injections in Discogenic Low Back Pain Associated With Modic Type-1 Change
Actual Study Start Date :
Oct 5, 2020
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Oct 5, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Modic Type-1 changes

Transforaminal Epidural Steroid Injection will be performed on patients at the pathology detected level bilaterally. The Kambin approach will be preferred in order to reach the intervertebral disc.

Drug: Dexamethasone-Lidocaine
Kambin's triangle approach in transforaminal epidural injection: Kambin's triangle is defined as a right triangle over the dorsolateral disc. The hypotenuse is the exiting nerve root, the base is the superior border of the caudal vertebra, and the height is the dura/traversing nerve root. it is possible to inject agents at the entrance and middle zone as the main areas of nerve entrapment by injecting at the retrodiscal area of the entrance zone, as proximal area of the targeted nerve root.
Other Names:
  • Transforaminal epidural steroid injection
  • Active Comparator: Degenerative disc disease without Modic Type-1 changes

    Transforaminal Epidural Steroid Injection will be performed on patients at the pathology detected level bilaterally. The Kambin approach will be preferred in order to reach the intervertebral disc.

    Drug: Dexamethasone-Lidocaine
    Kambin's triangle approach in transforaminal epidural injection: Kambin's triangle is defined as a right triangle over the dorsolateral disc. The hypotenuse is the exiting nerve root, the base is the superior border of the caudal vertebra, and the height is the dura/traversing nerve root. it is possible to inject agents at the entrance and middle zone as the main areas of nerve entrapment by injecting at the retrodiscal area of the entrance zone, as proximal area of the targeted nerve root.
    Other Names:
  • Transforaminal epidural steroid injection
  • Outcome Measures

    Primary Outcome Measures

    1. numeric rating scale [Baseline]

      a scale used to measure the severity of pain. "0" is scored as no pain, "10" as the most severe pain that could be. The patient scores between 0 and 10 for pain.

    2. numeric rating scale [first month]

      a scale used to measure the severity of pain. "0" is scored as no pain, "10" as the most

    3. numeric rating scale [third month]

      a scale used to measure the severity of pain. "0" is scored as no pain, "10" as the most

    4. numeric rating scale [sixth month]

      a scale used to measure the severity of pain. "0" is scored as no pain, "10" as the most

    Secondary Outcome Measures

    1. Oswestry disability index [Baseline]

      a functional disability index used in low back pain. The Oswestry Disability Index (ODI) consists of 10 items. The items question the severity of pain, self-care, lifting-carrying, walking, sitting, standing, sleep, the degree of pain change, travel and social life. There are six statements under each item, marking what is appropriate for the patient's condition. The first statement is scored as "0" and the sixth statement as "5". The higher the total score, the higher the level of disability.

    2. Oswestry disability index [first month]

      a functional disability index used in low back pain. The Oswestry Disability Index (ODI) consists of 10 items. The items question the severity of pain, self-care, lifting-carrying, walking, sitting, standing, sleep, the degree of pain change, travel and social life. There are six statements under each item, marking what is appropriate for the patient's condition. The first statement is scored as "0" and the sixth statement as "5". The higher the total score, the higher the level of disability.

    3. Oswestry disability index [third month]

      a functional disability index used in low back pain. The Oswestry Disability Index (ODI) consists of 10 items. The items question the severity of pain, self-care, lifting-carrying, walking, sitting, standing, sleep, the degree of pain change, travel and social life. There are six statements under each item, marking what is appropriate for the patient's condition. The first statement is scored as "0" and the sixth statement as "5". The higher the total score, the higher the level of disability.

    4. Oswestry disability index [sixth month]

      a functional disability index used in low back pain. The Oswestry Disability Index (ODI) consists of 10 items. The items question the severity of pain, self-care, lifting-carrying, walking, sitting, standing, sleep, the degree of pain change, travel and social life. There are six statements under each item, marking what is appropriate for the patient's condition. The first statement is scored as "0" and the sixth statement as "5". The higher the total score, the higher the level of disability.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Being between the ages of 18-65

    • Non-radicular, axial back pain

    • Lack of response to conservative treatments

    • Detection of Modic type 1 changes in contrast-enhanced Lumbar MRI or intervertebral disc findings that may be associated with discogenic pain (nuclear signal intensity change in the disc [black disc], height loss, or high-intensity zone)

    Exclusion Criteria:
    • Patients younger than 18 and older than 65

    • Describing pain radiating to the lower extremity (those with radicular pain)

    • Nerve root compression due to disc herniation or other reasons

    • Modic changes in more than one level

    • Positive facet loading test

    • Spinal stenosis or spondylolisthesis

    • Diagnosed with spondylodiscitis

    • Pregnancy

    • Patients with inflammatory rheumatic diseases

    • Patients whose use of non-steroidal anti-inflammatory drugs is contraindicated (renal failure, bleeding disorders, etc.)

    • Patients with exercise intolerance

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Marmara University, Faculty of Medicine Istanbul Turkey

    Sponsors and Collaborators

    • Marmara University

    Investigators

    • Principal Investigator: Serdar Kokar, M.D., Saniurfa Education and Research Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Marmara University
    ClinicalTrials.gov Identifier:
    NCT04930211
    Other Study ID Numbers:
    • 09.2020.961
    First Posted:
    Jun 18, 2021
    Last Update Posted:
    Aug 31, 2021
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Marmara University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 31, 2021